Wearable Injectors Market
Wearable Injectors Market Forecasts to 2030 - Global Analysis By Type (On-body and Off-body), By Usage Type (Disposable, Semi-Disposable and Reusable), Technology (Microfluidic Systems, Electronic Systems, Hybrid Systems and Other Technologies), Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $9.01 BN |
|
Projected Year Value (2030) |
US $19.80 BN |
|
CAGR (2023-2030) |
11.9% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Wearable Injectors Market is accounted for $9.01 billion in 2023 and is expected to reach $19.80 billion by 2030 growing at a CAGR of 11.9% during the forecast period. Wearable injectors are compact medical devices worn on the body, facilitating controlled and consistent drug delivery. These devices administer medication subcutaneously, offering convenience and precise dosing for patients with chronic conditions. They come in various forms, often incorporating electronic or mechanical systems, allowing for personalized treatment plans and enabling continuous or intermittent delivery of medications over extended periods.
According to the International Diabetes Federation, over 780 million people are expected to be living with diabetes, by 2045.
Market Dynamics:
Driver:
Increasing incidence of chronic illnesses
With an increasing prevalence of conditions like diabetes, cardiovascular diseases and autoimmune disorders, there's a growing demand for convenient and precise drug delivery methods. Wearable injectors offer a solution by providing patients with a means to self-administer medications, ensuring consistent dosing and improving treatment adherence. Their ability to accommodate long-term therapy for chronic conditions aligns with the need for enhanced patient convenience and efficient management of these ongoing health challenges, propelling their market growth.
Restraint:
Expenses associated with wearable injectors
The cost factor linked to wearable injectors poses a notable restraint in the market. These devices often entail high expenses due to their sophisticated technology, manufacturing intricacies, and specialized materials. This elevated cost can limit accessibility for some patients, impacting widespread adoption. Additionally, reimbursement challenges and healthcare budget constraints further impede their widespread use.
Opportunity:
Rising healthcare infrastructure and lifestyle disorders
As healthcare systems advance, there's increased emphasis on patient-centric care and innovative drug delivery methods. Wearable injectors align with this trend by offering a user-friendly, self-administered approach for managing chronic conditions prevalent in modern lifestyles. This convergence creates an opportunity for wearable injectors to address the needs of individuals with chronic illnesses, providing efficient and convenient drug delivery solutions, thereby fostering their adoption and market growth.
Threat:
Inclination towards alternative drug delivery systems?
While patients and healthcare providers explore diverse options like oral medications or traditional injections, the inclination away from wearable injectors challenges market growth. Factors such as patient preferences, cost considerations, and the development of competing technologies divert attention from wearable injector adoption. This trend might hinder the widespread acceptance of wearable injectors, impacting their market penetration and slowing the anticipated market expansion despite their advantages in precise and convenient drug delivery.
Covid-19 Impact:
The COVID-19 pandemic significantly influenced the wearable injectors market. Delayed elective procedures, reduced patient consultations and financial constraints led to a temporary slowdown in wearable injector adoption. However, the pandemic highlighted the need for remote healthcare solutions, potentially fostering long-term interest and innovation in wearable injectors as patients seek convenient, at-home treatment options amid healthcare disruptions.
The diabetes segment is expected to be the largest during the forecast period
The diabetes segment is poised to lead the wearable injectors market. With the escalating prevalence of diabetes worldwide, there's a growing demand for efficient and convenient drug delivery systems. Wearable injectors offer diabetic patients a way to manage insulin delivery conveniently, ensuring precise dosing and enhancing treatment adherence. Moreover, technological advancements and the development of user-friendly, integrated systems tailored for diabetes management further contribute to the dominance of this segment in the market.
The off-body injectors segment is expected to have the highest CAGR during the forecast period
The off-body injectors segment is set for substantial growth due to the device's portability and flexibility, allowing users to carry and administer medications conveniently without the constraints of being attached to the body. The trend towards more discreet and user-friendly drug delivery methods, especially for treatments requiring intermittent dosing or long-term therapies, drives the demand for off-body injectors. Additionally, their compatibility with various medications and their ability to accommodate diverse patient preferences contribute to their expansion within the wearable injectors market.
Region with largest share:
North America is expected to dominate the wearable injectors market due to a combination of advanced healthcare infrastructure, a high prevalence of chronic diseases and a tech-savvy population. The region's robust regulatory environment supports the adoption of innovative medical technologies. Rising healthcare expenditures and a strong presence of key market players further contribute to North America's leadership.
Region with highest CAGR:
Asia Pacific is positioned for significant growth in the wearable injectors market due to the region's expanding population, rising prevalence of chronic diseases and increasing healthcare awareness. Favorable government initiatives, improving healthcare infrastructure and the growing adoption of innovative technologies in countries like China, India, and Japan contribute to market expansion. Additionally, rising disposable incomes and a shift towards more patient-centric healthcare models in the region further propel the growth of wearable injectors in Asia Pacific.
Key players in the market
Some of the key players in wearable injectors market include Amgen Inc., Becton, Dickinson and Company, CeQur SA, Debiotech SA, E3D Elcam Drug Delivery Devices, Enable Injection Devices Ltd., Insulet Corporation, Medtronic plc, Nemera Development SA, ScPharmaceuticals Inc., Sensile Medical AG, SFC Fluidics, SteadyMed Therapeutics, Inc., Tandem Diabetes Care, Inc., Unilife Corporation, West Pharmaceutical Services, Inc. and Ypsomed Holding AG.
Key Developments:
In May 2023, Enable Injections, Inc. collaborated with Viridian Therapeutics, Inc., a U.S.-based biotechnology company.
In January 2023, Tandem Diabetes Care, Inc. announced the acquisition of AMF Medical SA, manufacturer of Sigi Patch Pump.
In June 2022, AbbVie received US FDA approval for SKYRIZI (risankizumab-rzaa) as the first and only specific interleukin-23 (IL-23) inhibitor for the treatment of adults with moderately to severely active Crohn's disease (CD). It can be self-administered by Subcutaneous Injection (SC) with an On-Body Injector (OBI).
Types Covered:
• On-body
• Off-body
Usage Types Covered:
• Disposable
• Semi-Disposable
• Reusable
Technologies Covered:
• Microfluidic Systems
• Electronic Systems
• Hybrid Systems
• Mechanical Systems
• Other Technologies
Applications Covered:
• Autoimmune Disease
• Cardiovascular Disease
• Diabetes
• Immunodeficiency
• Infectious Disease
• Oncology
• Other Applications
End Users Covered:
• Hospitals
• Clinics
• Home Care
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Wearable Injectors Market, By Type
5.1 Introduction
5.2 On-body
5.3 Off-body
6 Global Wearable Injectors Market, By Usage Type
6.1 Introduction
6.2 Disposable
6.3 Semi-Disposable
6.4 Reusable
7 Global Wearable Injectors Market, By Technology
7.1 Introduction
7.2 Microfluidic Systems
7.3 Electronic Systems
7.4 Hybrid Systems
7.5 Mechanical Systems
7.5.1 Balloon Reservoir
7.5.2 Infuser Pump
7.5.3 Oscillatory Systems
7.5.4 Rotary Mechanisms
7.5.5 Spring-Based
7.6 Other Technologies
8 Global Wearable Injectors Market, By Application
8.1 Introduction
8.2 Autoimmune Disease
8.3 Cardiovascular Disease
8.4 Diabetes
8.5 Immunodeficiency
8.6 Infectious Disease
8.7 Oncology
8.8 Other Applications
9 Global Wearable Injectors Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Home Care
9.5 Other End Users
10 Global Wearable Injectors Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Amgen Inc.
12.2 Becton, Dickinson and Company
12.3 CeQur SA
12.4 Debiotech SA
12.5 E3D Elcam Drug Delivery Devices
12.6 Enable Injection Devices Ltd.
12.7 Insulet Corporation
12.8 Medtronic plc
12.9 Nemera Development SA
12.10 ScPharmaceuticals Inc.
12.11 Sensile Medical AG
12.12 SFC Fluidics
12.13 SteadyMed Therapeutics, Inc.
12.14 Tandem Diabetes Care, Inc.
12.15 Unilife Corporation
12.16 West Pharmaceutical Services, Inc.
12.17 Ypsomed Holding AG
List of Tables
1 Global Wearable Injectors Market Outlook, By Region (2021-2030) ($MN)
2 Global Wearable Injectors Market Outlook, By Type (2021-2030) ($MN)
3 Global Wearable Injectors Market Outlook, By On-body (2021-2030) ($MN)
4 Global Wearable Injectors Market Outlook, By Off-body (2021-2030) ($MN)
5 Global Wearable Injectors Market Outlook, By Usage Type (2021-2030) ($MN)
6 Global Wearable Injectors Market Outlook, By Disposable (2021-2030) ($MN)
7 Global Wearable Injectors Market Outlook, By Semi-Disposable (2021-2030) ($MN)
8 Global Wearable Injectors Market Outlook, By Reusable (2021-2030) ($MN)
9 Global Wearable Injectors Market Outlook, By Technology (2021-2030) ($MN)
10 Global Wearable Injectors Market Outlook, By Microfluidic Systems (2021-2030) ($MN)
11 Global Wearable Injectors Market Outlook, By Electronic Systems (2021-2030) ($MN)
12 Global Wearable Injectors Market Outlook, By Hybrid Systems (2021-2030) ($MN)
13 Global Wearable Injectors Market Outlook, By Mechanical Systems (2021-2030) ($MN)
14 Global Wearable Injectors Market Outlook, By Balloon Reservoir (2021-2030) ($MN)
15 Global Wearable Injectors Market Outlook, By Infuser Pump (2021-2030) ($MN)
16 Global Wearable Injectors Market Outlook, By Oscillatory Systems (2021-2030) ($MN)
17 Global Wearable Injectors Market Outlook, By Rotary Mechanisms (2021-2030) ($MN)
18 Global Wearable Injectors Market Outlook, By Spring-Based (2021-2030) ($MN)
19 Global Wearable Injectors Market Outlook, By Other Technologies (2021-2030) ($MN)
20 Global Wearable Injectors Market Outlook, By Application (2021-2030) ($MN)
21 Global Wearable Injectors Market Outlook, By Autoimmune Disease (2021-2030) ($MN)
22 Global Wearable Injectors Market Outlook, By Cardiovascular Disease (2021-2030) ($MN)
23 Global Wearable Injectors Market Outlook, By Diabetes (2021-2030) ($MN)
24 Global Wearable Injectors Market Outlook, By Immunodeficiency (2021-2030) ($MN)
25 Global Wearable Injectors Market Outlook, By Infectious Disease (2021-2030) ($MN)
26 Global Wearable Injectors Market Outlook, By Oncology (2021-2030) ($MN)
27 Global Wearable Injectors Market Outlook, By Other Applications (2021-2030) ($MN)
28 Global Wearable Injectors Market Outlook, By End User (2021-2030) ($MN)
29 Global Wearable Injectors Market Outlook, By Hospitals (2021-2030) ($MN)
30 Global Wearable Injectors Market Outlook, By Clinics (2021-2030) ($MN)
31 Global Wearable Injectors Market Outlook, By Home Care (2021-2030) ($MN)
32 Global Wearable Injectors Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
